Treatment for facial alopecia areata: A systematic review with evidence-based analysis - 28/02/18
Doi : 10.1016/j.jaad.2017.09.054
Aizuri Murad, MRCS, MRCP a, b, ⁎ 
, Wilma Bergfeld, MD, FAAD b, c
, Wilma Bergfeld, MD, FAAD b, c a Department of Dermatology, Mater Misericordiae University Hospital, Dublin, Ireland
b Department of Dermatology, The Cleveland Clinic Foundation, Cleveland, Ohio
c Department of Dermatopathology, The Cleveland Clinic Foundation, Cleveland, Ohio
∗Correspondence to: Aizuri Murad, MRCS, MRCP, Department of Dermatology, Mater Misericordiae University Hospital, Dublin, IrelandDepartment of DermatologyMater Misericordiae University HospitalDublinIreland
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| Reprints not available from the authors. |
© 2017
American Academy of Dermatology, Inc. Tous droits réservés.
Vol 78 - N° 3
P. 601-605 - mars 2018 Retour au numéro
Article précédent
- Home-based contact immunotherapy with diphenylcyclopropenone for alopecia areata is as effective and safe as clinic-based treatment in patients with stable disease: A retrospective study of 40 patients
- Solam Lee, Won-Soo Lee
- Comparison of cyclic and continuous 308-nm excimer laser treatments for vitiligo: A randomized controlled noninferiority trial
- Jae Min Sung, Jung Min Bae, Hee Young Kang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?